Back to Search Start Over

Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy.

Authors :
Toussaint, Laura
Matysiak, Witold
Alapetite, Claire
Aristu, Javier
Bannink-Gawryszuk, Agata
Bolle, Stephanie
Bolsi, Alessandra
Calvo, Felipe
Cerron Campoo, Fernando
Charlwood, Frances
Demoor-Goldschmidt, Charlotte
Doyen, Jérôme
Drosik-Rutowicz, Katarzyna
Dutheil, Pauline
Embring, Anna
Engellau, Jacob
Goedgebeur, Anneleen
Goudjil, Farid
Harrabi, Semi
Kopec, Renata
Source :
Radiotherapy & Oncology. Sep2024, Vol. 198, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

• European patterns of practice for PBS-PT of paediatric PF tumours were assessed. • Diversity in clinical practice across Europe was demonstrated. • Collaboration between European PBS-PT centres treating paediatrics was established. As no guidelines for pencil beam scanning (PBS) proton therapy (PT) of paediatric posterior fossa (PF) tumours exist to date, this study investigated planning techniques across European PT centres, with special considerations for brainstem and spinal cord sparing. A survey and a treatment planning comparison were initiated across nineteen European PBS-PT centres treating paediatric patients. The survey assessed all aspects of the treatment chain, including but not limited to delineations, dose constraints and treatment planning. Each centre planned two PF tumour cases for focal irradiation, according to their own clinical practice but based on common delineations. The prescription dose was 54 Gy(RBE) for Case 1 and 59.4 Gy(RBE) for Case 2. For both cases, planning strategies and relevant dose metrics were compared. Seventeen (89 %) centres answered the survey, and sixteen (80 %) participated in the treatment planning comparison. In the survey, thirteen (68 %) centres reported using the European Particle Therapy Network definition for brainstem delineation. In the treatment planning study, while most centres used three beam directions, their configurations varied widely across centres. Large variations were also seen in brainstem doses, with a brainstem near maximum dose (D2%) ranging from 52.7 Gy(RBE) to 55.7 Gy(RBE) (Case 1), and from 56.8 Gy(RBE) to 60.9 Gy(RBE) (Case 2). This study assessed the European PBS-PT planning of paediatric PF tumours. Agreement was achieved in e.g. delineation-practice, while wider variations were observed in planning approach and consequently dose to organs at risk. Collaboration between centres is still ongoing, striving towards common guidelines. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01678140
Volume :
198
Database :
Academic Search Index
Journal :
Radiotherapy & Oncology
Publication Type :
Academic Journal
Accession number :
178832460
Full Text :
https://doi.org/10.1016/j.radonc.2024.110414